Functional Imaging & Neuromodulation via Ultrasonic BCI
Join the Imperial Neurotech Society for their first speaker-event of the year, and a chance to chat with Consultant Neurosurgeon / Clinician-Scientist Dr Aimun Jamjoom!
Based at Queen’s Hospital, Romford, he is Chief Investigator of the ARIA-funded Forest 1 study that aims to map and modulate dynamic brain states linked to mood using an ultrasound-based brain computer interface (BCI). The Forest 1 study lays the groundwork for a new generation of closed-loop therapeutic BCI for neuropsychiatric disorders.
Dr Jamjoom has partnered with Professor Elsa Fouragnan (Ex-DARPA, University of Plymouth, UKRI) and Sumner Norman (CEO of US-based FRO, Forest Neurotech). This team will utilise an ultrasonic neural interface called Forest 1 for advanced brain imaging and neuromodulation which allows for whole-brain, high-resolution imaging and precise multi-target neuromodulation.
They’ll leverage Forest 1’s unique capabilities to measure and modulate neural activity across different mood states, enabling the development of a predictive model of affective brain states. This model will be used to simulate and optimise neuromodulation strategies aimed at shifting brain states towards clinically meaningful outcomes. Their vision is for Forest 1 to become a transformative neurotechnology for a range of therapeutic applications. Read up on the project via The Guardian!
No prior background in neurotech or Imperial-affiliation is needed - open to all!